Asthma, Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
The aim of the study is to measure the inspiratory flow that the different patient groups (asthmatic children, adults and elderly, as well as chronic obstructive pulmonary disease (COPD) patients) generate through empty Easyhaler (two versions) and Turbuhaler inhalers. In addition, the handling and acceptability of the inhalers will be compared in asthmatic children.
Interventions
OTHEREmpty inhalers
Empty Easyhaler inhalers (type A and type B) and empty Turbohaler inhaler
Sponsors
Orion Corporation, Orion Pharma
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Written informed consent obtained. * Documented diagnosis of asthma and/or COPD (a range of different severities for both diseases). * Age: 6 years or above.
Exclusion criteria
* Any severe chronic respiratory disease other than asthma or COPD. * Acute respiratory infection. * Concurrent participation in a clinical drug study. * Inability to perform repeatable spirometric measurements. * Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study (such as contraindications to spirometry).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peak inspiratory flow rate through the empty Easyhaler and Turbohaler inhalers | 1 Day |
Secondary
| Measure | Time frame |
|---|---|
| Other inspiratory flow parameters through the empty Easyhaler and Turbohaler inhalers measured at the same time with the peak inspiratory flow rate. | 1 Day |
| Handling of the devices in the subpopulation of asthmatic children | 1 Day |
| Acceptability of the inhalers in the subpopulation of asthmatic children | 1 Day |
Countries
Finland, United Kingdom
Outcome results
None listed